462 related articles for article (PubMed ID: 31732967)
21. Poloxamer 188 rescues MPTP-induced lysosomal membrane integrity impairment in cellular and mouse models of Parkinson's disease.
Dong H; Qin Y; Huang Y; Ji D; Wu F
Neurochem Int; 2019 Jun; 126():178-186. PubMed ID: 30904670
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of long non-coding RNA AL049437 mitigates MPP+ -induced neuronal injury in SH-SY5Y cells via the microRNA-205-5p/MAPK1 axis.
Zhang L; Wang J; Liu Q; Xiao Z; Dai Q
Neurotoxicology; 2020 May; 78():29-35. PubMed ID: 32057949
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
24. MiR-124 Regulates Apoptosis and Autophagy Process in MPTP Model of Parkinson's Disease by Targeting to Bim.
Wang H; Ye Y; Zhu Z; Mo L; Lin C; Wang Q; Wang H; Gong X; He X; Lu G; Lu F; Zhang S
Brain Pathol; 2016 Mar; 26(2):167-76. PubMed ID: 25976060
[TBL] [Abstract][Full Text] [Related]
25. LncRNA HOTAIR Promotes Neuronal Damage Through Facilitating NLRP3 Mediated-Pyroptosis Activation in Parkinson's Disease via Regulation of miR-326/ELAVL1 Axis.
Zhang Q; Huang XM; Liao JX; Dong YK; Zhu JL; He CC; Huang J; Tang YW; Wu D; Tian JY
Cell Mol Neurobiol; 2021 Nov; 41(8):1773-1786. PubMed ID: 32968928
[TBL] [Abstract][Full Text] [Related]
26. LncRNA XIST sponges miR-199a-3p to modulate the Sp1/LRRK2 signal pathway to accelerate Parkinson's disease progression.
Zhou Q; Zhang MM; Liu M; Tan ZG; Qin QL; Jiang YG
Aging (Albany NY); 2021 Jan; 13(3):4115-4137. PubMed ID: 33494069
[No Abstract] [Full Text] [Related]
27. MicroRNA-214 participates in the neuroprotective effect of Resveratrol via inhibiting α-synuclein expression in MPTP-induced Parkinson's disease mouse.
Wang ZH; Zhang JL; Duan YL; Zhang QS; Li GF; Zheng DL
Biomed Pharmacother; 2015 Aug; 74():252-6. PubMed ID: 26349993
[TBL] [Abstract][Full Text] [Related]
28. MiR-212 Attenuates MPP⁺-Induced Neuronal Damage by Targeting KLF4 in SH-SY5Y Cells.
Song Y; Liu Y; Chen X
Yonsei Med J; 2018 May; 59(3):416-424. PubMed ID: 29611404
[TBL] [Abstract][Full Text] [Related]
29. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra.
Heng Y; Zhang QS; Mu Z; Hu JF; Yuan YH; Chen NH
Toxicol Lett; 2016 Jan; 243():7-21. PubMed ID: 26723869
[TBL] [Abstract][Full Text] [Related]
30. Regulatory mechanism of miR-20a-5p in neuronal damage and inflammation in lipopolysaccharide-induced BV2 cells and MPTP-HCl-induced Parkinson's disease mice.
Gao Y; Sheng D; Chen W
Psychogeriatrics; 2024 Apr; ():. PubMed ID: 38664198
[TBL] [Abstract][Full Text] [Related]
31. Long Noncoding RNA SNHG1 Promotes Neuroinflammation in Parkinson's Disease via Regulating miR-7/NLRP3 Pathway.
Cao B; Wang T; Qu Q; Kang T; Yang Q
Neuroscience; 2018 Sep; 388():118-127. PubMed ID: 30031125
[TBL] [Abstract][Full Text] [Related]
32. LncRNA SNHG15 mediates 1-methyl-4-phenylpyridinium (MPP
Li J; Sun Z; Song L
Neurol Res; 2023 Feb; 45(2):181-190. PubMed ID: 36384413
[TBL] [Abstract][Full Text] [Related]
33. miR-135b Plays a Neuroprotective Role by Targeting GSK3β in MPP
Zhang J; Liu W; Wang Y; Zhao S; Chang N
Dis Markers; 2017; 2017():5806146. PubMed ID: 28484287
[TBL] [Abstract][Full Text] [Related]
34. Thymoquinone prevents neurodegeneration against MPTP in vivo and modulates α-synuclein aggregation in vitro.
Ardah MT; Merghani MM; Haque ME
Neurochem Int; 2019 Sep; 128():115-126. PubMed ID: 31028778
[TBL] [Abstract][Full Text] [Related]
35. FTY720 Inhibits MPP
Yao S; Li L; Sun X; Hua J; Zhang K; Hao L; Liu L; Shi D; Zhou H
J Neuroimmune Pharmacol; 2019 Sep; 14(3):478-492. PubMed ID: 31069623
[TBL] [Abstract][Full Text] [Related]
36. The long noncoding RNA GAS5 potentiates neuronal injury in Parkinson's disease by binding to microRNA-150 to regulate Fosl1 expression.
Ma J; Sun W; Chen S; Wang Z; Zheng J; Shi X; Li M; Li D; Gu Q
Exp Neurol; 2022 Jan; 347():113904. PubMed ID: 34755654
[TBL] [Abstract][Full Text] [Related]
37. Eupatilin prevents behavioral deficits and dopaminergic neuron degeneration in a Parkinson's disease mouse model.
Zhang Y; Qin L; Xie J; Li J; Wang C
Life Sci; 2020 Jul; 253():117745. PubMed ID: 32376269
[TBL] [Abstract][Full Text] [Related]
38. Amentoflavone protects dopaminergic neurons in MPTP-induced Parkinson's disease model mice through PI3K/Akt and ERK signaling pathways.
Cao Q; Qin L; Huang F; Wang X; Yang L; Shi H; Wu H; Zhang B; Chen Z; Wu X
Toxicol Appl Pharmacol; 2017 Mar; 319():80-90. PubMed ID: 28185818
[TBL] [Abstract][Full Text] [Related]
39. Suppressed microRNA-96 inhibits iNOS expression and dopaminergic neuron apoptosis through inactivating the MAPK signaling pathway by targeting CACNG5 in mice with Parkinson's disease.
Dong Y; Han LL; Xu ZX
Mol Med; 2018 Nov; 24(1):61. PubMed ID: 30486773
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-93 Blocks Signal Transducers and Activator of Transcription 3 to Reduce Neuronal Damage in Parkinson's Disease.
Wang X; Liu Z; Wang F
Neurochem Res; 2021 Jul; 46(7):1859-1868. PubMed ID: 33900518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
